On June 14, 2024, Regulations and Rulings issued an internal advice decision, HQ H283420, concerning country of origin marking requirements for repackaged prescription medication Imported into the United States. This ruling may be accessed on the Customs Rulings Online Search System (CROSS) at the following link: https://rulings.cbp.gov/home.
Pursuant to the decision, all repackaged medications sold to retail customers will be required to be marked with the country of origin. The Fact Sheet referenced and found at the link directly below discusses the country of origin marking requirements applicable to prescription medication imported into the United States: https://www.cbp.gov/document/fact-sheets/marking-prescription-drugs-retail-sale-factsheet.
If you have any questions, please contact the Pharmaceutical Center at PHCMarking@cbp.dhs.gov.
https://content.govdelivery.com/bulletins/gd/USDHSCBP-3b38a48?wgt_ref=USDHSCBP_WIDGET_2
